Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Modeling MRSA decolonization: Interactions between body sites and the impact of site-specific clearance

View ORCID ProfileOnur Poyraz, View ORCID ProfileMohamad R. A. Sater, Loren G. Miller, James A. McKinnell, Susan S. Huang, View ORCID ProfileYonatan H. Grad, View ORCID ProfilePekka Marttinen
doi: https://doi.org/10.1101/2020.11.30.20239798
Onur Poyraz
1Computer Science, Aalto University, School of Science
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Onur Poyraz
  • For correspondence: onur.poyraz@aalto.fi
Mohamad R. A. Sater
2Immunology and Infectious Diseases, Harvard TH Chan, School of Public Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mohamad R. A. Sater
Loren G. Miller
3Infectious Diseases, Lundquist Institute, Harbor-UCLA Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James A. McKinnell
3Infectious Diseases, Lundquist Institute, Harbor-UCLA Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan S. Huang
4Infectious Diseases, University of California Irvine, School of Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yonatan H. Grad
5Immunology and Infectious Diseases, Harvard TH Chan, School of Public Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yonatan H. Grad
Pekka Marttinen
6Computer Science, Aalto University, School of Science
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Pekka Marttinen
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) colonizes multiple body sites, and carriage is an important risk factor for MRSA infection. Successful decolonization reduces disease incidence; however, the optimal decolonization protocol is unclear. Decolonization protocols include diverse sets of treatments that target multiple body sites, and standard methods can not estimate the impact of site-specific components from such data. Here, we formulated a Bayesian coupled hidden Markov Model (CHMM) for MRSA colonization dynamics that estimates interactions between body sites and quantifies the contribution of each component on successful decolonization. Importantly, this now makes it possible 1) to predict the efficiency of decolonization for any combination of site-specific treatments, including combinations not included in the data, and 2) to assess the impact of enhancing site-specific clearance on the success of decolonization. We applied the model to longitudinal data from a randomized controlled trial (RCT) of MRSA decolonization, including chlorhexidine (CHG) body and mouthwash and nasal mupirocin. Our findings confirmed that nares are central to MRSA persistence and act as a predominant source of colonization for other body sites. We estimated the CHG mouthwash as the least effective component, such that the combined effect of clearance on other sites accounted for as much as 97% (90% credible interval 90%-99%) of the full decolonization. Hence, the omission of CHG mouthwash still yields a highly efficient decolonization regimen while facilitating adherence. Finally, we used our model to estimate the effectiveness of hypothetical treatment improvements in silico and showed that enhancing MRSA clearance at nares will achieve the largest gains. This study demonstrates the use of advanced probabilistic modeling to go beyond what is typically achieved by RCTs, enabling evidence-based decision-making to streamline clinical protocols.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT01209234

Clinical Protocols

https://doi.org/10.1056/NEJMoa1716771

Funding Statement

No external funding was received.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

We used the data from https://doi.org/10.1056/NEJMoa1716771. This trial was approved by the institutional review board of the University of California Irvine. For more details about the data collection, please see the original article https://doi.org/10.1056/NEJMoa1716771

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • onur.poyraz{at}aalto.fi, msater{at}hsph.harvard.edu, lmiller{at}lundquist.org,jmckinnell{at}lundquist.org, sshuang{at}hs.uci.edu, ygrad{at}hsph.harvard.edu, pekka.marttinen{at}aalto.fi

  • Title is changed The methods section is updated Results are revised Model convergence is shown

Data Availability

The CLEAR (Changing Lives by Eradicating Antibiotic Resistance) Trial demonstrated that the use of a post-discharge decolonization protocol in MRSA carriers reduces infection and hospitalization rates; ClinicalTrial.gov number NCT01209234, see reference https://doi.org/10.1056/NEJMoa1716771 for informed consent and institutional review board approvals. The data used in the present article is available on request from the corresponding author Susan Huang of the https://doi.org/10.1056/NEJMoa1716771, a co-author of this study.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted March 03, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Modeling MRSA decolonization: Interactions between body sites and the impact of site-specific clearance
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Modeling MRSA decolonization: Interactions between body sites and the impact of site-specific clearance
Onur Poyraz, Mohamad R. A. Sater, Loren G. Miller, James A. McKinnell, Susan S. Huang, Yonatan H. Grad, Pekka Marttinen
medRxiv 2020.11.30.20239798; doi: https://doi.org/10.1101/2020.11.30.20239798
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Modeling MRSA decolonization: Interactions between body sites and the impact of site-specific clearance
Onur Poyraz, Mohamad R. A. Sater, Loren G. Miller, James A. McKinnell, Susan S. Huang, Yonatan H. Grad, Pekka Marttinen
medRxiv 2020.11.30.20239798; doi: https://doi.org/10.1101/2020.11.30.20239798

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (271)
  • Allergy and Immunology (557)
  • Anesthesia (135)
  • Cardiovascular Medicine (1769)
  • Dentistry and Oral Medicine (239)
  • Dermatology (173)
  • Emergency Medicine (316)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (662)
  • Epidemiology (10812)
  • Forensic Medicine (8)
  • Gastroenterology (594)
  • Genetic and Genomic Medicine (2960)
  • Geriatric Medicine (288)
  • Health Economics (534)
  • Health Informatics (1933)
  • Health Policy (836)
  • Health Systems and Quality Improvement (745)
  • Hematology (293)
  • HIV/AIDS (633)
  • Infectious Diseases (except HIV/AIDS) (12525)
  • Intensive Care and Critical Care Medicine (696)
  • Medical Education (300)
  • Medical Ethics (87)
  • Nephrology (324)
  • Neurology (2809)
  • Nursing (152)
  • Nutrition (433)
  • Obstetrics and Gynecology (560)
  • Occupational and Environmental Health (597)
  • Oncology (1473)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (257)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (381)
  • Pediatrics (868)
  • Pharmacology and Therapeutics (367)
  • Primary Care Research (338)
  • Psychiatry and Clinical Psychology (2647)
  • Public and Global Health (5383)
  • Radiology and Imaging (1016)
  • Rehabilitation Medicine and Physical Therapy (597)
  • Respiratory Medicine (727)
  • Rheumatology (330)
  • Sexual and Reproductive Health (290)
  • Sports Medicine (279)
  • Surgery (327)
  • Toxicology (48)
  • Transplantation (150)
  • Urology (126)